Shares of financial Services company Comerica got downgraded by Goldman Sachs.
Goldman analysts lowered their rating on the stock to sell from neutral. They also slashed their price target on the shares to $70 from $86.
Analyst Ryan Nash cautioned clients in a note that the Federal Reserve’s interest rate cuts could offset Comerica’s commendable actions at boosting loan growth, controlling costs and returning capital. Nash pointed out that Comerica’s disclosures indicate that its NII (net interest income) will decline by 12% from a 200bp decrease in rates (100bp average) compared to its peers' disclosures at a lower 5%. Nash further added that while Comerica has invested in $2.8 billion of swaps to hedge the interest rate risks, his team estimates that the company would need an additional $20 billion-$24 billion to be sufficiently hedged.
According to Nash, several expense advantages in 2019 that helped Comerica to keep costs flat are unlikely to repeat (FDIC costs, GEAR up savings). He also noted that most of its excess capital has been used up.
The Moving Average Convergence Divergence (MACD) for CMA turned positive on March 04, 2026. Looking at past instances where CMA's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on February 13, 2026. You may want to consider a long position or call options on CMA as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
CMA moved below its 50-day moving average on February 09, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CMA crossed bearishly below the 50-day moving average on February 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Aroon Indicator for CMA entered a downward trend on March 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CMA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock slightly worse than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.551) is normal, around the industry mean (1.154). P/E Ratio (16.794) is within average values for comparable stocks, (16.961). CMA's Projected Growth (PEG Ratio) (16.351) is very high in comparison to the industry average of (3.266). Dividend Yield (0.032) settles around the average of (0.036) among similar stocks. P/S Ratio (3.451) is also within normal values, averaging (5.838).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a major bank
Industry RegionalBanks